410 likes | 539 Views
Cancer results from mutations in genes regulating cell growth. Two classes of genes are involved: 1) - positive regulators promote cancer by hyperactivity (one allele is enough)
E N D
Cancer results from mutations in genes regulating cell growth • Two classes of genes are involved: • 1) - positive regulators promote cancer by hyperactivity (one allele is enough) • 2) - negative regulators, promote cancer by loss of activity (two allele must be mutated) Oncogenes Suppressor genes
Rb • The first tumor suppressor- (retinoblastoma) • The most frequent mutated tumor suppressor - • p53 was first cloned at the weizmann institute and is mutated in > 50% of all cancer. • 25,000 papers published on p53 in 22 years p53 How p53 functions as a tumor suppressor?
Induction of cell death by active p53 Parental M1 M1-p53Val135clones at 32oC
Activation of temperature sensitive p53 prevents transformation Myc + Ras + no p53 temperature sensitive p53 ts p53 in mutant conformation ts p53 in wild type conformation
Negative regulation of DNA binding Protein-protein interactions, Transcriptional repression apotosis
(Ko LJ & Prives C, Genes & Dev. 10:1054-1072, 1996) Most of p53 mutations are found in the conserved regions of the central DNA binding domain
Activated p53 Transactivation Other activities (C terminal = TFIIH binding?) (N terminal = SH3 binding?) p21/ Waf1 Bax, IGF-BP3, Fas, killer/DR5, Noxa, PIG3, p53AIP1, PIDD, Puma Other genes etc, etc, etc Apoptosis Growth arrest
Growth arrest, apoptosis Functional p53 DNA damage, oncogene activation Loss of p53 function Cancer
Three Experimental Systems 1. Primary and Secondary Targets of p53 2. Target genes related to apoptosis 3. Comparison of p53 and p73 A chip of 10,000 genes is more than ten thousand northern blots
Filter hybridization MDM2 LIG1 PCNA p21
DIRECT AND INDIRECT TARGETS CHX INHIBITS PROTEIN SYNTHESIS AND PREVENTS ACTIVATION OF SECONDARY TARGETS
Only ˜10% of the genes changed expression in all 3 repeats(Coller et al. 2000) Primary p53 target genes in presence of CHX 38 24
Clustering of 259 genes upregulated without CHX at least three times > 2.5 fold a. 9 genes (false?) b. All 38 primary c. 87% of primary
GENE/ PROTEIN NAME p21waf1 MIC1 - member of TGF-b family MDM2 PCNA GADD45 Mitochondrial Stress 70 (Mortalin2) p57KIP2-CDK inhibitor 1C PIG3-p53 induced gene 3 FAS/APO1 BAX-Bcl2 associated X protein BAK1- Bcl2 antagonist/killer 1 38.0 10.0 8.3 3.9 3.0 1.5 11.0 3.8 3.7 1.5 p53 - Upregulated Genes in H1299-Val135 system RATIO FUNCTION CELL CYCLE APOPTOSIS
GENE/ PROTEIN NAME DDB2-Nucleotide Excision Repair LIG1 - DNA ligase 1 ERCC5 - DNA Excision Repair related TDG - G/T mismatch DNA Glycosylase RPA1 - Replication Factor A Protein 1 MAPK14 MAP4K5 Activaes Jun N-term Kinase MAP2K1 - MEK1 MYD88 - Myeloid differentiation Retinoic Acid Receptor Beta FKBP4 HOXD3 - Homeobox protein CSPG2 - Chondroitin sulfate proteoglycan 2 6.5 2.3 1.9 1.8 1.6 3.8 1.6 1.5 5.4 4.6 3.1 1.8 2.0 P53 - Upregulated Genes in H1299-Val135 system RATIO FUNCTION DNA REPAIR KINASE RECEPTOR DEVELOP. IMMUNOPHIL. DEVELOP. ECM
p53- DRIVEN APOPTOSIS A different cell line (M1) that undergoes apoptosis by p53 at 32
APOPTOSIS : - Apoptosis is a genetically controlled program of cell death, also referred to as cell suicide or Programmed Cell Death (PCD). - It is an evolutionary conserved mechanism. • - It ultimately leads to elimination of undesired cells • either superfluous • or potentially harmful when damaged - It plays an essential role during developmental as well as adult stages by allowing tissue remodeling, tissue renewal and maintenance of tissue homeostasis
Pro apop Anti apop
A B 12h M1 2h LTR6 2h M1 2h M1 C D 9h LTR6 12h LTR6 2h M1 2h M1 SCATTER PLOTS OF 404 GENES THAT WERE REGULATED BY P53 IN LTR6 CELLS
M1 2hr M1 12hr LTR6 2hr Control Cell type M1 LTR6 M1 LTR6 M1 LTR6 12 2 6 9 12 2 2 6 9 12 12 2 6 9 12 Time (hr) A B C D E F Clustering of 404 genes based on expression kinetics at 32C
Kinetics of transcriptional activation Cluster E Cluster C Cluster D Relative ratio M1 2 6 9 12 M1 2 6 9 12 M1 2 6 9 12
Apoptosis related genes upregulated by p53 H1299 Val Cells RATIO OF EXPRESSION (12h) ACCESSION NO. X63717 U82987 U00115 U16811 MOUSE ACCESSION NO. AB021961 M83649 U82532 J04953 Z16410 AW060710 X74504 AF064071 Fas/APO-1 cell surface antigen Bcl-2 binding component 3 (bbc3) PUMA Bcl-6 Bak p53 Fas antigen/TNFR6 TNFR18 Gelsolin Btg1 EST=PIG8 (Etoposide induced) T10 mRNA/human sentrin/SUMO-1 Apaf-1 9.8 30.5 6.8 7.4 57.8 54.5 11.3 2.9 9.0 6.2 4.3 7.2 LTR 6 Cells HUMAN ACCESSION NO. A1909620 X89101 A1923712 X04412 X61123 R11732 U83117 AL135220
Northern Analysis of LTR6 Cells Apaf-1 mRNA induced at 32 C by ts-p53
APAF-1 promoter contains p53 target at -604 bp 800 400 • RRRCWWGYYY N{0-13 bp} RRRCWWGYYY • APAF-1 AGACATGTCT GGAGACCCTAGGA cGACAAGCCC • BAX tcACAAGTTa G AGACAAGCCT • GADD45 GAACATGTCT AAGCATGCTg • MDM2 GGtCAAGTTg GGACAcGTCC
p53 Binding to APAF-1 Target by Gel Shift Analysis Others Ab x’sX x’sA Oligo A A A A A A B C D p53 + + + + mut + + + Oligo A: AGACATGTCTGGAGACCCTAGGACGACAAGCCC Oligo B: AGACATGTCT CGACAAGCCC Oligo C: AGACATGTCTGGAGACCGACAAGCCC Oligo D: AGAaATGTCTGGAGACCCTAGGACGAaAAGCCC
Apoptotic stimuli p53 Bax PUMA Bcl-2 Cyt c /dATP Smac p53 Apaf-1 Caspase-9 IAPs Caspase-3 Cellular targets Apoptosis
p53 family members Comparison of p73 and p53 induced genes